0

Close
 
2022
Shockwave Therapy Market

Shockwave Therapy Market

by Technique (Electrohydraulic Technique, Piezoelectric Technique, Radial Technique, Electromagnetic Shock Waves), by Product (Mobile Shockwave Therapy Devices, Fixed Shockwave Therapy Devices), by Application (Orthopedics, Cardiology, Urology, Others), by End User (Hospitals, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

LS : Medical Devices & Supplies
Report Code: A13380
Dec 2022 | Pages: 234
Tables: 173
Charts: 63

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

Shockwave Therapy Market Research, 2031

The global Shockwave Therapy Market Size was valued at $1,171.19 million in 2021 and is projected to reach $2,269.62 million by 2031, registering a CAGR of 6.8% from 2022 to 2031.  Shock wave therapy (SWT) is an FDA-approved technology that involves the non-invasive treatment of chronic, painful conditions of the musculoskeletal system by employing intense, shock waves that travel faster than the speed of sound. SWT devices are electronic devices used to generate low-energy sound waves which travel through the targeted area via a gel medium, thus repairing the tissue by causing mechanical stress and stimulating the body to jump into action. Shockwave therapy has a wide range of applications in physiotherapy, sports medicine, veterinary medicine, plastic surgery, and others. 

The overall impact of COVID-19 remains negative on the shockwave therapy market. Owing to decline in the number of surgical procedures worldwide, all outpatient treatments were postponed or restricted during the COVID-19 pandemic to reduce the risk of viral transmission as most chronic therapies were regarded as non-urgent. Moreover, the COVID-19 pandemic also impacted the number of sports-tournament which are organized worldwide, which reduces the prevalence rate of sports-related injuries. Furthermore, it is expected that the sales of the shockwave therapy market will rapidly increase post covid phase, owing to the increasingly sedentary lifestyle practices are giving rise to chronic spinal ailments and back problems.

Shockwave Therapy Market

Historical overview 

The market was analyzed qualitatively and quantitatively from 2018-2020. Most of the growth during this period was derived from the Asia-Pacific owing to the rise in the prevalence of musculoskeletal diseases, sports-related injuries, and road accidents, the increase in the geriatric population, improving health awareness, rising disposable incomes, as well as the well-established presence of domestic companies in the region.   

Market dynamics 

The rise in the prevalence of sports-related injuries increases the cases of muscle and tendon disorders is the major factor boosting the Shockwave Therapy Market Growth. For instance, according to the data published by National Safety Council, it has been reported that with regard to exercise and exercise equipment injuries, the number of injuries increased slightly in 2021 (409,224 injuries in 2021 compared to 377,939 in 2020), the application with the highest injury rate is 15- to 24-year-olds, nearly twice as many males are injured as females (4,148,404 males vs. 2,158,887 females), and 91% of injury victims are treated in emergency departments and released. Furthermore, the surge in the number of road accidents and increasing ailments and chronic diseases among the population have also led to an increase in demand for better and technologically advanced shockwave therapy devices that boosts the market growth. Moreover, the increase in the number of R&D activities in the field of shockwave therapy kits or medical devices enhanced healthcare services, and significant investments by the government to improve healthcare infrastructure have become vital tools for small and large businesses globally. This is attributed to further support market growth. The demand for shockwave therapy is not only limited to developed countries but is also being witnessed in developing countries, such as China, Brazil, and India, which provides a lucrative Shockwave Therapy Market Opportunity in upcoming years.  

The outbreak of COVID-19 has disrupted workflows in the healthcare sector around the world. The disease has forced several industries to shut their doors temporarily, including several sub-domains of health care. The global shockwave therapy market experienced a decrease in 2020 as the pandemic significantly impacted the number of sports-tournament which are organized worldwide, which reduces the prevalence rate of sports-related injuries. However, the market is anticipated to witness steady growth in 2021 and is anticipated to grow at a significant CAGR during the forecast period for the shockwave therapy market. This is attributed to the increasingly sedentary lifestyle practices that are giving rise to chronic spinal ailments and back problems. These disorders require proper management and treatment in order to achieve the best results. In addition, the increase in the number of cardiovascular diseases among people as a result of sedentary lifestyle practices proves to be a great opportunity for the shockwave therapy market. The lack of physical activity among people increases the number of chronic diseases in society and has led to the increase in demand for better and more advanced technologies for therapeutic purposes to reduce pain within a shorter period of time than usual.    

Segmental Overview 

The shockwave therapy market is segmented on the basis of technology, type, application, end-user, and region. By technology, the market is segmented into electrohydraulic shockwaves, electromagnetic shockwaves, piezoelectric shockwaves, and radial shockwaves. By type, it is classified into mobile and fixed. By application, it is bifurcated into urology, orthopedics, cardiology, and others. By end user, the market is segmented into hospitals, clinics, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

By technology, the market is segmented into electrohydraulic shockwaves, electromagnetic shockwaves, piezoelectric shockwaves, and radial shockwaves. The electrohydraulic shockwaves segment has largest Shockwave Therapy Market Sharein 2021 and is expected to remain dominant throughout the forecast period, owing to the widespread use of electrohydraulic shock wave therapy for orthopedic physiotherapy in elderly patients in order to treat lithotripsy.  

Shockwave Therapy Market

Based on type, the Shockwave Therapy Industry is segmented into mobile and fixed. The mobile segment dominated the global market in 2021 and is expected to remain dominant throughout the forecast period, owing to its flexibility and mobility also it is easily accessible from remote places where the patient can't be brought to the hospital setup. 

Shockwave Therapy Market

By application, it is bifurcated into urology, orthopedics, cardiology, and others. The orthopedic segment has the largest Shockwave Therapy Market Share in 2021 and is anticipated to continue this trend during the forecast period. This is attributed to increases in the prevalence of musculoskeletal disorders, sports-related injuries, arthritis, and bone diseases, as well as rising geriatric populations.  

Shockwave Therapy Market

By end user, the Shockwave Therapy Industry is segmented into hospitals, clinics, and others. The hospital segment dominated the global market in 2021 and is anticipated to continue this trend during the forecast period. This is attributed to the advantages offered such as hospitals providing specialized, individualized therapeutic, and emergency care for patients with symptoms of chronic muscular and tendon disorders, back and neck pain along with sports injuries. Hospitals are better equipped to handle any post-operative complications and they include facilities for physical rehabilitation post surgeries are the key factors that drive the growth of the market in upcoming years.   

Shockwave Therapy Market

By region, The shockwave therapy market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for a major share of the shockwave therapy market in 2021 and is expected to maintain its dominance during the forecast period. The presence of several major players and the advancement in technology of shockwave therapy devices in the region drive the growth of the market. The shockwave therapy market is mainly driven by the presence of well-established healthcare facilities, a growing geriatric population, and the rising prevalence of sports-related injuries and cardiovascular disorders. Moreover, an increase in the prevalence of arthritis and musculoskeletal disorders is contributing to the market growth in the region. Furthermore, increasing investment by pharmaceutical companies in R&D activities to design technologically advanced medical devices through innovative research is expected to fuel the Shockwave Therapy Market Size in this region. 

Asia-Pacific is expected to grow at the highest rate during the forecast period. The market growth in this region is attributable to the presence of pharmaceutical companies in the region as well as the rise in the geriatric population of the countries, such as China and India. Moreover, the rise in the number of chronic and cardiovascular diseases, and an increase in the number of road accidents drive the growth of the market. Furthermore, the Asia-Pacific region exhibits the largest supply of medical devices and the largest pharmaceutical industry with the availability of technologically advanced medical devices in abundance, which can be easily accessed by consumers. This, in turn, drives the growth of the market. Asia-Pacific offers profitable opportunities for key players operating in the shockwave therapy market, thereby registering the fastest growth rate during the forecast period, owing to the growing infrastructure of industries, rising disposable incomes, as well as the well-established presence of domestic companies in the region. In addition, increased technological innovations and heavy funding by government and private organizations, and increased investment by companies in R&D activities are expected to provide great opportunities for the growth of the market in this region.   

Shockwave Therapy Market

COMPETITION ANALYSIS 

  • Competitive analysis and profiles of the major players in the shockwave therapy market, such as BioMed India, Boston Scientific Corporation, BTL Corporate, Dornier MedTech, EDAP TMS, EMS Dolorclast, Inceler Medikal Co. Ltd, Karl Storz SE & Co, SANUWAVE and SANUWAVE Health, Inc. and Shockwave Medical Inc are provided in this report. Major players have adopted product launches, product expansions, and acquisitions as key developmental strategies to improve the product portfolio of the shockwave therapy market.   

Some examples of product launches in the market 

Product launch in the market  

  • In March 2022, Shockwave Medical, Inc. launched its Shockwave M5+ peripheral IVL catheter after receiving both CE Mark and U.S. Food and Drug Administration (FDA) clearance. The Shockwave M5+ catheter is specifically designed to decrease IVL treatment time, provide alternative access options, and expand IVL therapy to patients with larger vessel sizes. 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the shockwave therapy market analysis from 2021 to 2031 to identify the prevailing shockwave therapy market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the shockwave therapy market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global shockwave therapy market trends, key players, market segments, application areas, and market growth strategies.

 Shockwave Therapy Market Report Highlights

Aspects Details
Market Size By 2031 USD 2.3 billion
Growth Rate CAGR of 6.8%
Forecast period 2021 - 2031
Report Pages 234
By Technique
  • Electrohydraulic Technique
  • Piezoelectric Technique
  • Radial Technique
  • Electromagnetic Shock Waves
By Product
  • Mobile Shockwave Therapy Devices
  • Fixed Shockwave Therapy Devices
By End User
  • Hospitals
  • Clinics
  • Others
By Application
  • Urology
  • Others
  • Orthopedics
  • Cardiology
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Boston Scientific Corporation, Bio-Med Inc., Shockwave Medical, Inc, Inceler Medikal Co. Ltd., KARL STORZ SE & Co. KG, EMS Dolorclast, Dornier MedTech, BTL Industries, EDAP TMS, SANUWAVE & SANUWAVE Health, Inc
 

  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Market dynamics

      • 3.4.1.Drivers

        • 3.4.1.1. Increasing incidence of muscle and tendon disorder and sports-related injuries
        • 3.4.1.2. Rise in technological advancement
        • 3.4.1.3. Rise in chronic and musculoskeletal disorder

      • 3.4.2.Restraints

        • 3.4.2.1. High cost of the treatment

      • 3.4.3.Opportunities

        • 3.4.3.1. High growth potential in developing economies

    • 3.5.COVID-19 Impact Analysis on the market

  • CHAPTER 4: SHOCKWAVE THERAPY MARKET, BY TECHNIQUE

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2. Electrohydraulic Technique

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market share analysis by country

    • 4.3. Piezoelectric Technique

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market share analysis by country

    • 4.4. Radial Technique

      • 4.4.1 Key market trends, growth factors and opportunities

      • 4.4.2 Market size and forecast, by region

      • 4.4.3 Market share analysis by country

    • 4.5. Electromagnetic Shock Waves

      • 4.5.1 Key market trends, growth factors and opportunities

      • 4.5.2 Market size and forecast, by region

      • 4.5.3 Market share analysis by country

  • CHAPTER 5: SHOCKWAVE THERAPY MARKET, BY PRODUCT

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2. Mobile Shockwave Therapy Devices

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market share analysis by country

    • 5.3. Fixed Shockwave Therapy Devices

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market share analysis by country

  • CHAPTER 6: SHOCKWAVE THERAPY MARKET, BY APPLICATION

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2. Orthopedics

      • 6.2.1 Key market trends, growth factors and opportunities

      • 6.2.2 Market size and forecast, by region

      • 6.2.3 Market share analysis by country

    • 6.3. Cardiology

      • 6.3.1 Key market trends, growth factors and opportunities

      • 6.3.2 Market size and forecast, by region

      • 6.3.3 Market share analysis by country

    • 6.4. Urology

      • 6.4.1 Key market trends, growth factors and opportunities

      • 6.4.2 Market size and forecast, by region

      • 6.4.3 Market share analysis by country

    • 6.5. Others

      • 6.5.1 Key market trends, growth factors and opportunities

      • 6.5.2 Market size and forecast, by region

      • 6.5.3 Market share analysis by country

  • CHAPTER 7: SHOCKWAVE THERAPY MARKET, BY END USER

    • 7.1 Overview

      • 7.1.1 Market size and forecast

    • 7.2. Hospitals

      • 7.2.1 Key market trends, growth factors and opportunities

      • 7.2.2 Market size and forecast, by region

      • 7.2.3 Market share analysis by country

    • 7.3. Clinics

      • 7.3.1 Key market trends, growth factors and opportunities

      • 7.3.2 Market size and forecast, by region

      • 7.3.3 Market share analysis by country

    • 7.4. Others

      • 7.4.1 Key market trends, growth factors and opportunities

      • 7.4.2 Market size and forecast, by region

      • 7.4.3 Market share analysis by country

  • CHAPTER 8: SHOCKWAVE THERAPY MARKET, BY REGION

    • 8.1 Overview

      • 8.1.1 Market size and forecast

    • 8.2 North America

      • 8.2.1 Key trends and opportunities

      • 8.2.2 North America Market size and forecast, by Technique

      • 8.2.3 North America Market size and forecast, by Product

      • 8.2.4 North America Market size and forecast, by Application

      • 8.2.5 North America Market size and forecast, by End User

      • 8.2.6 North America Market size and forecast, by country

        • 8.2.6.1 U.S.
          • 8.2.6.1.1 Key market trends, growth factors and opportunities
          • 8.2.6.1.2 Market size and forecast, by Technique
          • 8.2.6.1.3 Market size and forecast, by Product
          • 8.2.6.1.4 Market size and forecast, by Application
          • 8.2.6.1.5 Market size and forecast, by End User
        • 8.2.6.2 Canada
          • 8.2.6.2.1 Key market trends, growth factors and opportunities
          • 8.2.6.2.2 Market size and forecast, by Technique
          • 8.2.6.2.3 Market size and forecast, by Product
          • 8.2.6.2.4 Market size and forecast, by Application
          • 8.2.6.2.5 Market size and forecast, by End User
        • 8.2.6.3 Mexico
          • 8.2.6.3.1 Key market trends, growth factors and opportunities
          • 8.2.6.3.2 Market size and forecast, by Technique
          • 8.2.6.3.3 Market size and forecast, by Product
          • 8.2.6.3.4 Market size and forecast, by Application
          • 8.2.6.3.5 Market size and forecast, by End User

    • 8.3 Europe

      • 8.3.1 Key trends and opportunities

      • 8.3.2 Europe Market size and forecast, by Technique

      • 8.3.3 Europe Market size and forecast, by Product

      • 8.3.4 Europe Market size and forecast, by Application

      • 8.3.5 Europe Market size and forecast, by End User

      • 8.3.6 Europe Market size and forecast, by country

        • 8.3.6.1 Germany
          • 8.3.6.1.1 Key market trends, growth factors and opportunities
          • 8.3.6.1.2 Market size and forecast, by Technique
          • 8.3.6.1.3 Market size and forecast, by Product
          • 8.3.6.1.4 Market size and forecast, by Application
          • 8.3.6.1.5 Market size and forecast, by End User
        • 8.3.6.2 France
          • 8.3.6.2.1 Key market trends, growth factors and opportunities
          • 8.3.6.2.2 Market size and forecast, by Technique
          • 8.3.6.2.3 Market size and forecast, by Product
          • 8.3.6.2.4 Market size and forecast, by Application
          • 8.3.6.2.5 Market size and forecast, by End User
        • 8.3.6.3 UK
          • 8.3.6.3.1 Key market trends, growth factors and opportunities
          • 8.3.6.3.2 Market size and forecast, by Technique
          • 8.3.6.3.3 Market size and forecast, by Product
          • 8.3.6.3.4 Market size and forecast, by Application
          • 8.3.6.3.5 Market size and forecast, by End User
        • 8.3.6.4 Italy
          • 8.3.6.4.1 Key market trends, growth factors and opportunities
          • 8.3.6.4.2 Market size and forecast, by Technique
          • 8.3.6.4.3 Market size and forecast, by Product
          • 8.3.6.4.4 Market size and forecast, by Application
          • 8.3.6.4.5 Market size and forecast, by End User
        • 8.3.6.5 Spain
          • 8.3.6.5.1 Key market trends, growth factors and opportunities
          • 8.3.6.5.2 Market size and forecast, by Technique
          • 8.3.6.5.3 Market size and forecast, by Product
          • 8.3.6.5.4 Market size and forecast, by Application
          • 8.3.6.5.5 Market size and forecast, by End User
        • 8.3.6.6 Rest of Europe
          • 8.3.6.6.1 Key market trends, growth factors and opportunities
          • 8.3.6.6.2 Market size and forecast, by Technique
          • 8.3.6.6.3 Market size and forecast, by Product
          • 8.3.6.6.4 Market size and forecast, by Application
          • 8.3.6.6.5 Market size and forecast, by End User

    • 8.4 Asia-Pacific

      • 8.4.1 Key trends and opportunities

      • 8.4.2 Asia-Pacific Market size and forecast, by Technique

      • 8.4.3 Asia-Pacific Market size and forecast, by Product

      • 8.4.4 Asia-Pacific Market size and forecast, by Application

      • 8.4.5 Asia-Pacific Market size and forecast, by End User

      • 8.4.6 Asia-Pacific Market size and forecast, by country

        • 8.4.6.1 Japan
          • 8.4.6.1.1 Key market trends, growth factors and opportunities
          • 8.4.6.1.2 Market size and forecast, by Technique
          • 8.4.6.1.3 Market size and forecast, by Product
          • 8.4.6.1.4 Market size and forecast, by Application
          • 8.4.6.1.5 Market size and forecast, by End User
        • 8.4.6.2 China
          • 8.4.6.2.1 Key market trends, growth factors and opportunities
          • 8.4.6.2.2 Market size and forecast, by Technique
          • 8.4.6.2.3 Market size and forecast, by Product
          • 8.4.6.2.4 Market size and forecast, by Application
          • 8.4.6.2.5 Market size and forecast, by End User
        • 8.4.6.3 Australia
          • 8.4.6.3.1 Key market trends, growth factors and opportunities
          • 8.4.6.3.2 Market size and forecast, by Technique
          • 8.4.6.3.3 Market size and forecast, by Product
          • 8.4.6.3.4 Market size and forecast, by Application
          • 8.4.6.3.5 Market size and forecast, by End User
        • 8.4.6.4 India
          • 8.4.6.4.1 Key market trends, growth factors and opportunities
          • 8.4.6.4.2 Market size and forecast, by Technique
          • 8.4.6.4.3 Market size and forecast, by Product
          • 8.4.6.4.4 Market size and forecast, by Application
          • 8.4.6.4.5 Market size and forecast, by End User
        • 8.4.6.5 South Korea
          • 8.4.6.5.1 Key market trends, growth factors and opportunities
          • 8.4.6.5.2 Market size and forecast, by Technique
          • 8.4.6.5.3 Market size and forecast, by Product
          • 8.4.6.5.4 Market size and forecast, by Application
          • 8.4.6.5.5 Market size and forecast, by End User
        • 8.4.6.6 Rest of Asia-Pacific
          • 8.4.6.6.1 Key market trends, growth factors and opportunities
          • 8.4.6.6.2 Market size and forecast, by Technique
          • 8.4.6.6.3 Market size and forecast, by Product
          • 8.4.6.6.4 Market size and forecast, by Application
          • 8.4.6.6.5 Market size and forecast, by End User

    • 8.5 LAMEA

      • 8.5.1 Key trends and opportunities

      • 8.5.2 LAMEA Market size and forecast, by Technique

      • 8.5.3 LAMEA Market size and forecast, by Product

      • 8.5.4 LAMEA Market size and forecast, by Application

      • 8.5.5 LAMEA Market size and forecast, by End User

      • 8.5.6 LAMEA Market size and forecast, by country

        • 8.5.6.1 Brazil
          • 8.5.6.1.1 Key market trends, growth factors and opportunities
          • 8.5.6.1.2 Market size and forecast, by Technique
          • 8.5.6.1.3 Market size and forecast, by Product
          • 8.5.6.1.4 Market size and forecast, by Application
          • 8.5.6.1.5 Market size and forecast, by End User
        • 8.5.6.2 Saudi Arabia
          • 8.5.6.2.1 Key market trends, growth factors and opportunities
          • 8.5.6.2.2 Market size and forecast, by Technique
          • 8.5.6.2.3 Market size and forecast, by Product
          • 8.5.6.2.4 Market size and forecast, by Application
          • 8.5.6.2.5 Market size and forecast, by End User
        • 8.5.6.3 South Africa
          • 8.5.6.3.1 Key market trends, growth factors and opportunities
          • 8.5.6.3.2 Market size and forecast, by Technique
          • 8.5.6.3.3 Market size and forecast, by Product
          • 8.5.6.3.4 Market size and forecast, by Application
          • 8.5.6.3.5 Market size and forecast, by End User
        • 8.5.6.4 Rest of LAMEA
          • 8.5.6.4.1 Key market trends, growth factors and opportunities
          • 8.5.6.4.2 Market size and forecast, by Technique
          • 8.5.6.4.3 Market size and forecast, by Product
          • 8.5.6.4.4 Market size and forecast, by Application
          • 8.5.6.4.5 Market size and forecast, by End User

  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top winning strategies

    • 9.3. Product Mapping of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top player positioning, 2021

  • CHAPTER 10: COMPANY PROFILES

    • 10.1 EDAP TMS

      • 10.1.1 Company overview

      • 10.1.2 Key Executives

      • 10.1.3 Company snapshot

      • 10.1.4 Operating business segments

      • 10.1.5 Product portfolio

      • 10.1.6 Business performance

      • 10.1.7 Key strategic moves and developments

    • 10.2 Bio-Med Inc.

      • 10.2.1 Company overview

      • 10.2.2 Key Executives

      • 10.2.3 Company snapshot

      • 10.2.4 Operating business segments

      • 10.2.5 Product portfolio

      • 10.2.6 Business performance

      • 10.2.7 Key strategic moves and developments

    • 10.3 Dornier MedTech

      • 10.3.1 Company overview

      • 10.3.2 Key Executives

      • 10.3.3 Company snapshot

      • 10.3.4 Operating business segments

      • 10.3.5 Product portfolio

      • 10.3.6 Business performance

      • 10.3.7 Key strategic moves and developments

    • 10.4 KARL STORZ SE & Co. KG

      • 10.4.1 Company overview

      • 10.4.2 Key Executives

      • 10.4.3 Company snapshot

      • 10.4.4 Operating business segments

      • 10.4.5 Product portfolio

      • 10.4.6 Business performance

      • 10.4.7 Key strategic moves and developments

    • 10.5 Boston Scientific Corporation

      • 10.5.1 Company overview

      • 10.5.2 Key Executives

      • 10.5.3 Company snapshot

      • 10.5.4 Operating business segments

      • 10.5.5 Product portfolio

      • 10.5.6 Business performance

      • 10.5.7 Key strategic moves and developments

    • 10.6 BTL Industries

      • 10.6.1 Company overview

      • 10.6.2 Key Executives

      • 10.6.3 Company snapshot

      • 10.6.4 Operating business segments

      • 10.6.5 Product portfolio

      • 10.6.6 Business performance

      • 10.6.7 Key strategic moves and developments

    • 10.7 Shockwave Medical, Inc

      • 10.7.1 Company overview

      • 10.7.2 Key Executives

      • 10.7.3 Company snapshot

      • 10.7.4 Operating business segments

      • 10.7.5 Product portfolio

      • 10.7.6 Business performance

      • 10.7.7 Key strategic moves and developments

    • 10.8 SANUWAVE & SANUWAVE Health, Inc

      • 10.8.1 Company overview

      • 10.8.2 Key Executives

      • 10.8.3 Company snapshot

      • 10.8.4 Operating business segments

      • 10.8.5 Product portfolio

      • 10.8.6 Business performance

      • 10.8.7 Key strategic moves and developments

    • 10.9 Inceler Medikal Co. Ltd.

      • 10.9.1 Company overview

      • 10.9.2 Key Executives

      • 10.9.3 Company snapshot

      • 10.9.4 Operating business segments

      • 10.9.5 Product portfolio

      • 10.9.6 Business performance

      • 10.9.7 Key strategic moves and developments

    • 10.10 EMS Dolorclast

      • 10.10.1 Company overview

      • 10.10.2 Key Executives

      • 10.10.3 Company snapshot

      • 10.10.4 Operating business segments

      • 10.10.5 Product portfolio

      • 10.10.6 Business performance

      • 10.10.7 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 2. SHOCKWAVE THERAPY MARKET FOR ELECTROHYDRAULIC TECHNIQUE, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 3. SHOCKWAVE THERAPY MARKET FOR PIEZOELECTRIC TECHNIQUE, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 4. SHOCKWAVE THERAPY MARKET FOR RADIAL TECHNIQUE, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 5. SHOCKWAVE THERAPY MARKET FOR ELECTROMAGNETIC SHOCK WAVES, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 6. GLOBAL SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 7. SHOCKWAVE THERAPY MARKET FOR MOBILE SHOCKWAVE THERAPY DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 8. SHOCKWAVE THERAPY MARKET FOR FIXED SHOCKWAVE THERAPY DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 9. GLOBAL SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 10. SHOCKWAVE THERAPY MARKET FOR ORTHOPEDICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 11. SHOCKWAVE THERAPY MARKET FOR CARDIOLOGY, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 12. SHOCKWAVE THERAPY MARKET FOR UROLOGY, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 13. SHOCKWAVE THERAPY MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 14. GLOBAL SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 15. SHOCKWAVE THERAPY MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 16. SHOCKWAVE THERAPY MARKET FOR CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 17. SHOCKWAVE THERAPY MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 18. SHOCKWAVE THERAPY MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 19. NORTH AMERICA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 20. NORTH AMERICA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 21. NORTH AMERICA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 22. NORTH AMERICA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 23. NORTH AMERICA SHOCKWAVE THERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 24. U.S. SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 25. U.S. SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 26. U.S. SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 27. U.S. SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 28. CANADA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 29. CANADA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 30. CANADA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 31. CANADA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 32. MEXICO SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 33. MEXICO SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 34. MEXICO SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 35. MEXICO SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 36. EUROPE SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 37. EUROPE SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 38. EUROPE SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 39. EUROPE SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 40. EUROPE SHOCKWAVE THERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 41. GERMANY SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 42. GERMANY SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 43. GERMANY SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 44. GERMANY SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 45. FRANCE SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 46. FRANCE SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 47. FRANCE SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 48. FRANCE SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 49. UK SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 50. UK SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 51. UK SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 52. UK SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 53. ITALY SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 54. ITALY SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 55. ITALY SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 56. ITALY SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 57. SPAIN SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 58. SPAIN SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 59. SPAIN SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 60. SPAIN SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 61. REST OF EUROPE SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 62. REST OF EUROPE SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 63. REST OF EUROPE SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 64. REST OF EUROPE SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 65. ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 66. ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 67. ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 68. ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 69. ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 70. JAPAN SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 71. JAPAN SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 72. JAPAN SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 73. JAPAN SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 74. CHINA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 75. CHINA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 76. CHINA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 77. CHINA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 78. AUSTRALIA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 79. AUSTRALIA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 80. AUSTRALIA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 81. AUSTRALIA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 82. INDIA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 83. INDIA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 84. INDIA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 85. INDIA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 86. SOUTH KOREA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 87. SOUTH KOREA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 88. SOUTH KOREA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 89. SOUTH KOREA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 90. REST OF ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 91. REST OF ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 92. REST OF ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 93. REST OF ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 94. LAMEA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 95. LAMEA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 96. LAMEA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 97. LAMEA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 98. LAMEA SHOCKWAVE THERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 99. BRAZIL SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 100. BRAZIL SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 101. BRAZIL SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 102. BRAZIL SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 103. SAUDI ARABIA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 104. SAUDI ARABIA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 105. SAUDI ARABIA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 106. SAUDI ARABIA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 107. SOUTH AFRICA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 108. SOUTH AFRICA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 109. SOUTH AFRICA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 110. SOUTH AFRICA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 111. REST OF LAMEA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
    TABLE 112. REST OF LAMEA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 113. REST OF LAMEA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 114. REST OF LAMEA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 115. EDAP TMS: KEY EXECUTIVES
    TABLE 116. EDAP TMS: COMPANY SNAPSHOT
    TABLE 117. EDAP TMS: OPERATING SEGMENTS
    TABLE 118. EDAP TMS: PRODUCT PORTFOLIO
    TABLE 119. EDAP TMS: NET SALES
    TABLE 120. EDAP TMS: KEY STRATERGIES
    TABLE 121. BIO-MED INC.: KEY EXECUTIVES
    TABLE 122. BIO-MED INC.: COMPANY SNAPSHOT
    TABLE 123. BIO-MED INC.: OPERATING SEGMENTS
    TABLE 124. BIO-MED INC.: PRODUCT PORTFOLIO
    TABLE 125. BIO-MED INC.: NET SALES
    TABLE 126. BIO-MED INC.: KEY STRATERGIES
    TABLE 127. DORNIER MEDTECH: KEY EXECUTIVES
    TABLE 128. DORNIER MEDTECH: COMPANY SNAPSHOT
    TABLE 129. DORNIER MEDTECH: OPERATING SEGMENTS
    TABLE 130. DORNIER MEDTECH: PRODUCT PORTFOLIO
    TABLE 131. DORNIER MEDTECH: NET SALES
    TABLE 132. DORNIER MEDTECH: KEY STRATERGIES
    TABLE 133. KARL STORZ SE & CO. KG: KEY EXECUTIVES
    TABLE 134. KARL STORZ SE & CO. KG: COMPANY SNAPSHOT
    TABLE 135. KARL STORZ SE & CO. KG: OPERATING SEGMENTS
    TABLE 136. KARL STORZ SE & CO. KG: PRODUCT PORTFOLIO
    TABLE 137. KARL STORZ SE & CO. KG: NET SALES
    TABLE 138. KARL STORZ SE & CO. KG: KEY STRATERGIES
    TABLE 139. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
    TABLE 140. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
    TABLE 141. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
    TABLE 142. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
    TABLE 143. BOSTON SCIENTIFIC CORPORATION: NET SALES
    TABLE 144. BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
    TABLE 145. BTL INDUSTRIES: KEY EXECUTIVES
    TABLE 146. BTL INDUSTRIES: COMPANY SNAPSHOT
    TABLE 147. BTL INDUSTRIES: OPERATING SEGMENTS
    TABLE 148. BTL INDUSTRIES: PRODUCT PORTFOLIO
    TABLE 149. BTL INDUSTRIES: NET SALES
    TABLE 150. BTL INDUSTRIES: KEY STRATERGIES
    TABLE 151. SHOCKWAVE MEDICAL, INC: KEY EXECUTIVES
    TABLE 152. SHOCKWAVE MEDICAL, INC: COMPANY SNAPSHOT
    TABLE 153. SHOCKWAVE MEDICAL, INC: OPERATING SEGMENTS
    TABLE 154. SHOCKWAVE MEDICAL, INC: PRODUCT PORTFOLIO
    TABLE 155. SHOCKWAVE MEDICAL, INC: NET SALES
    TABLE 156. SHOCKWAVE MEDICAL, INC: KEY STRATERGIES
    TABLE 157. SANUWAVE & SANUWAVE HEALTH, INC: KEY EXECUTIVES
    TABLE 158. SANUWAVE & SANUWAVE HEALTH, INC: COMPANY SNAPSHOT
    TABLE 159. SANUWAVE & SANUWAVE HEALTH, INC: OPERATING SEGMENTS
    TABLE 160. SANUWAVE & SANUWAVE HEALTH, INC: PRODUCT PORTFOLIO
    TABLE 161. SANUWAVE & SANUWAVE HEALTH, INC: NET SALES
    TABLE 162. SANUWAVE & SANUWAVE HEALTH, INC: KEY STRATERGIES
    TABLE 163. INCELER MEDIKAL CO. LTD.: KEY EXECUTIVES
    TABLE 164. INCELER MEDIKAL CO. LTD.: COMPANY SNAPSHOT
    TABLE 165. INCELER MEDIKAL CO. LTD.: OPERATING SEGMENTS
    TABLE 166. INCELER MEDIKAL CO. LTD.: PRODUCT PORTFOLIO
    TABLE 167. INCELER MEDIKAL CO. LTD.: NET SALES
    TABLE 168. INCELER MEDIKAL CO. LTD.: KEY STRATERGIES
    TABLE 169. EMS DOLORCLAST: KEY EXECUTIVES
    TABLE 170. EMS DOLORCLAST: COMPANY SNAPSHOT
    TABLE 171. EMS DOLORCLAST: OPERATING SEGMENTS
    TABLE 172. EMS DOLORCLAST: PRODUCT PORTFOLIO
    TABLE 173. EMS DOLORCLAST: NET SALES
    TABLE 174. EMS DOLORCLAST: KEY STRATERGIES

  • LIST OF FIGURES

  • FIGURE 1. SEGMENTATION OF SHOCKWAVE THERAPY MARKET,2021-2031
    FIGURE 2. SHOCKWAVE THERAPY MARKET,2021-2031
    FIGURE 3. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 4. PORTER FIVE-1
    FIGURE 5. PORTER FIVE-2
    FIGURE 6. PORTER FIVE-3
    FIGURE 7. PORTER FIVE-4
    FIGURE 8. PORTER FIVE-5
    FIGURE 9. SHOCKWAVE THERAPY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 10. SHOCKWAVE THERAPY MARKET,BY TECHNIQUE,2021(%)
    FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ELECTROHYDRAULIC TECHNIQUE SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
    FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PIEZOELECTRIC TECHNIQUE SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
    FIGURE 13. COMPARATIVE SHARE ANALYSIS OF RADIAL TECHNIQUE SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
    FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ELECTROMAGNETIC SHOCK WAVES SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
    FIGURE 15. SHOCKWAVE THERAPY MARKET,BY PRODUCT,2021(%)
    FIGURE 16. COMPARATIVE SHARE ANALYSIS OF MOBILE SHOCKWAVE THERAPY DEVICES SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
    FIGURE 17. COMPARATIVE SHARE ANALYSIS OF FIXED SHOCKWAVE THERAPY DEVICES SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
    FIGURE 18. SHOCKWAVE THERAPY MARKET,BY APPLICATION,2021(%)
    FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ORTHOPEDICS SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
    FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CARDIOLOGY SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
    FIGURE 21. COMPARATIVE SHARE ANALYSIS OF UROLOGY SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
    FIGURE 22. COMPARATIVE SHARE ANALYSIS OF OTHERS SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
    FIGURE 23. SHOCKWAVE THERAPY MARKET,BY END USER,2021(%)
    FIGURE 24. COMPARATIVE SHARE ANALYSIS OF HOSPITALS SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
    FIGURE 25. COMPARATIVE SHARE ANALYSIS OF CLINICS SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
    FIGURE 26. COMPARATIVE SHARE ANALYSIS OF OTHERS SHOCKWAVE THERAPY MARKET, 2021 AND 2031(%)
    FIGURE 27. SHOCKWAVE THERAPY MARKET BY REGION,2021
    FIGURE 28. U.S. SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
    FIGURE 29. CANADA SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
    FIGURE 30. MEXICO SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
    FIGURE 31. GERMANY SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
    FIGURE 32. FRANCE SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
    FIGURE 33. UK SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
    FIGURE 34. ITALY SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
    FIGURE 35. SPAIN SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
    FIGURE 36. REST OF EUROPE SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
    FIGURE 37. JAPAN SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
    FIGURE 38. CHINA SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
    FIGURE 39. AUSTRALIA SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
    FIGURE 40. INDIA SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
    FIGURE 41. SOUTH KOREA SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
    FIGURE 42. REST OF ASIA-PACIFIC SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
    FIGURE 43. BRAZIL SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
    FIGURE 44. SAUDI ARABIA SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
    FIGURE 45. SOUTH AFRICA SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
    FIGURE 46. REST OF LAMEA SHOCKWAVE THERAPY MARKET,2021-2031($MILLION)
    FIGURE 47. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 50. PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 51. COMPETITIVE DASHBOARD
    FIGURE 52. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 53. TOP PLAYER POSITIONING, 2021
    FIGURE 54. EDAP TMS.: NET SALES ($MILLION)
    FIGURE 55. BIO-MED INC..: NET SALES ($MILLION)
    FIGURE 56. DORNIER MEDTECH.: NET SALES ($MILLION)
    FIGURE 57. KARL STORZ SE & CO. KG.: NET SALES ($MILLION)
    FIGURE 58. BOSTON SCIENTIFIC CORPORATION.: NET SALES ($MILLION)
    FIGURE 59. BTL INDUSTRIES.: NET SALES ($MILLION)
    FIGURE 60. SHOCKWAVE MEDICAL, INC.: NET SALES ($MILLION)
    FIGURE 61. SANUWAVE & SANUWAVE HEALTH, INC.: NET SALES ($MILLION)
    FIGURE 62. INCELER MEDIKAL CO. LTD..: NET SALES ($MILLION)
    FIGURE 63. EMS DOLORCLAST.: NET SALES ($MILLION)

 
 

This section provides various opinions of top-level CXOs in the shockwave therapy market. According to several interviews conducted, the shockwave therapy market is expected to witness significant growth in the future, owing to an increase in the number of muscle and tendon injuries, a surge in the number of cardiovascular diseases, and a rise in the number of geriatric populations. 

According to the perspectives of CXOs, the shockwave therapy market is expected to witness steady growth in the future. The increasing ailments and chronic diseases among the population have also led to the increase in demand for better and more advanced technologies for therapeutic purposes anticipated to fuel the market growth. The surge in investments in R&D by pharmaceutical companies, the growing healthcare expenditure, and the rise in technological advancement are the key factors driving the growth of the market. However, the high cost associated with advanced technologies, and the rise in the expensive treatment cost hampers the growth of the market up to some extent over the forecast period.  

As per CXOs, North America is expected to dominate the global shockwave therapy market during the forecast period, followed by Europe. In addition, emerging economies such as India, China, Mexico, and Brazil are expected to offer lucrative opportunities owing to the lack of medical facilities and supplies in these countries leading to the development of chronic ailments which require shockwave therapy for better recovery. 

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The trends of the shockwave therapy market are the rise in the prevalence of sports-related injuries and the increase the in cases of muscle and tendon disorders is the major factor boosting the growth of the market.

A. The forecast period in the report is from 2022 to 2031

A. North America is the largest regional market for Shockwave Therapy

A. $2,269.62 Million is the estimated industry size of Shockwave Therapy

A. BioMed India, Boston Scientific Corporation, BTL Corporate, Dornier MedTech, EDAP TMS, EMS Dolorclast, Inceler Medikal Co. Ltd, Karl Storz SE & Co, SANUWAVE and SANUWAVE Health, Inc. and Shockwave Medical Inc are the top companies to hold the market share in Shockwave Therapy

A. The base year for the report is 2021

A. Yes, Shockwave Therapymarket companies are profiled in the report

A. No, there is value chain analysis provided in the Shockwave Therapy market report

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Shockwave Therapy Market

Start reading instantly.
This Report and over 68,246+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Dec 2023 - Dec 2024)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Dec 2023 - Dec 2024)
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Dec 2023 - Dec 2024)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Dec 2023 - Dec 2024)

  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Dec 2023 - Dec 2024)

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers